Last month, the FDA issued a press release that changed the date product could stay on the shelves that was not FDA approved. The date changed from August 8, 2018 to August 8th, 2021. In that press release was language that stated, “Under expected revised timelines, applications for newly-regulated combustible products, such as cigars, pipe tobacco and hookah tobacco, would be submitted by Aug. 8, 2021.” In an email with the FDA today a Food […]
Today, Commissioner of the U.S. Food & Drug Administration, Dr. Scott Gottlieb, announced a new comprehensive plan for the approach the agency will take to the regulation of tobacco products, placing an emphasis on a science-based method, that notes a “continuum of risk” that recognizes the differences in tobacco products. Importantly, Dr. Gottlieb stated that FDA will reexamine the treatment of premium cigars under the agency’s current regulatory structure. Ultimately, the agency will open a […]
The FDA issued a press release that announced comprehensive regulatory plan to shift trajectory of tobacco-related disease, death and to pursue lowering nicotine in cigarettes to non-addictive levels and create more predictability in tobacco regulation. The agency plans to issue this guidance describing a new enforcement policy shortly. Under expected revised timelines, applications for newly-regulated combustible products, such as cigars, pipe tobacco and hookah tobacco, would be submitted by Aug. 8, 2021, and applications for […]
Yesterday, the House Appropriations Subcommittee on Agriculture passed legislation that includes a provision exempting premium cigars from FDA regulations. The provision, which applies the same definition for premium cigars as included in stand alone legislation already introduced and supported by over a quarter of Congress, applies the exemption for one full Fiscal Year (October 1, 2017 – September 30, 2018). The path forward for the bill remains long. The full Appropriations Committee must now consider […]
The FDA has issued a revised guidance with new compliance deadlines for retailers and manufacturers. Below are highlights of the newly promulgated schedule. New Deadline Highlights Submission of cigar warning plans (August 10th, 2017) Manufacturer registration & product listing (September 30th, 2017) SE exemption requests (November 8th, 2017) Submission of health documents & ingredient listings (November 8th, 2017) Submission of SE Reports for non-grandfathered products (May 8th, 2018) Implementation of required health warnings and labeling […]
Earlier today the United States Senate confirmed Dr. Scott Gottlieb as the next Commissioner of the Food & Drug Administration (FDA). IPCPR applauds the Senate’s decision to put thoughtful and experienced leadership at the head of an organization as critical as the FDA. Dr. Gottlieb’s confirmation puts a reform minded physician with experience in both the public and private sectors in charge of a regulatory body that has too often failed in its mission to […]
A rebellion. A group of freedom fights have signed up in support of the cigar industry against the tyrannical reign of the FDA. This group is in the form of states Arizona, Louisiana, Michigan and Texas for filed a 27 page brief opposing the FDA regulations of cigars. The brief which was filed on February 21 is part of the lawsuit which will be heard on July 28th, 2017 that puts plaintiffs Cigar Association of America, Cigar […]
According to a member of the Cigar Association of New Hampshire the bill that proposed the addition of a 65% tax on premium cigars has been defeated by more than a 3-1 margin with many politicians from both sides of the aisle voting against the increase. Additionally, HB 175 passed last week which changes the definition of a cigar bar. The original bill stated, “Does not allow cigarette smoking or service of food on the […]
WASHINGTON, D.C. – Yesterday, in the U.S. District Court for the District of Columbia, the Cigar Association of America, the International Premium Cigar & Pipe Retailers Association and Cigar Rights of America filed a Motion for Summary Judgment and opening brief in the cigar industry’s litigation challenging the FDA’s Final Deeming Rule. This filing serves as the next phase in the premium cigar industry’s joint litigation challenging FDA’s Final Deeming Rule, which began earlier this year in July […]
The FDA refers to a tobacco product that was commercially marketed (other than exclusively in test markets) in the U.S. as of Feb. 15, 2007, as a “grandfathered” tobacco product. These grandfathered products are not subject to the premarket requirements of the Federal Food, Drug, and Cosmetic Act and may serve as the predicate tobacco product in an application demonstrating substantial equivalence (SE) for a new tobacco product. The FDA’s new database contains determination information […]